
Results
65
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
65 companies
PharmaEngine
Market Cap: NT$9.7b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$67.80
7D
1.0%
1Y
-31.0%
Fidson Healthcare
Market Cap: ₦97.1b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦42.30
7D
-0.1%
1Y
168.6%
Exelixis
Market Cap: US$9.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$38.05
7D
-3.0%
1Y
35.4%
CytomX Therapeutics
Market Cap: US$559.1m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$3.30
7D
0.6%
1Y
205.6%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م5.0b
A drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م219.01
7D
19.0%
1Y
271.2%
Puma Biotechnology
Market Cap: US$263.4m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.04
7D
-6.8%
1Y
80.0%
Catalyst Pharmaceuticals
Market Cap: US$2.6b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.73
7D
1.0%
1Y
-3.2%
Merck
Market Cap: US$218.8b
Operates as a healthcare company worldwide.
MRK
US$87.18
7D
3.9%
1Y
-17.7%
BioStem Technologies
Market Cap: US$81.9m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.86
7D
3.1%
1Y
-65.3%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.18
7D
0.7%
1Y
82.9%
AstraZeneca Pharma India
Market Cap: ₹232.5b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹9,290.25
7D
1.4%
1Y
30.1%
AGP
Market Cap: PK₨56.3b
Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.
AGP
PK₨201.14
7D
1.6%
1Y
55.7%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.7b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س152.80
7D
-4.4%
1Y
-7.4%
Genmab
Market Cap: DKK 119.3b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,938.00
7D
-9.2%
1Y
22.8%
JW Lifescience
Market Cap: ₩208.0b
Provides national infusion solutions in South Korea and internationally.
A234080
₩13,250.00
7D
5.9%
1Y
22.6%
Blue Jet Healthcare
Market Cap: ₹112.9b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹644.70
7D
-1.3%
1Y
36.5%
TTY Biopharm
Market Cap: NT$20.3b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$81.60
7D
-0.5%
1Y
11.0%
Harmony Biosciences Holdings
Market Cap: US$1.5b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$29.60
7D
14.1%
1Y
-13.1%
Lupin
Market Cap: ₹886.1b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹1,931.40
7D
-0.4%
1Y
-10.4%
Hoechst Pakistan
Market Cap: PK₨41.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,232.23
7D
5.1%
1Y
80.1%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.6b
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
AXPH
ج.م912.19
7D
10.1%
1Y
229.6%
ChemoMetec
Market Cap: DKK 12.1b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 697.00
7D
6.4%
1Y
67.4%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥17.8b
Engages in the research and development, production, and sale of ophthalmic medications in the People’s Republic of China.
300573
CN¥74.28
7D
4.1%
1Y
5.7%
WuXi AppTec
Market Cap: CN¥299.7b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥103.81
7D
7.5%
1Y
95.9%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹467.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,750.25
7D
0.3%
1Y
6.3%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م4.0b
Engages in the manufacturing and sale of pharmaceuticals, medical preparations, cosmetics, and materials in Egypt.
CPCI
ج.م268.42
7D
14.4%
1Y
189.0%
Medpace Holdings
Market Cap: US$15.4b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$596.61
7D
14.5%
1Y
81.8%
ADMA Biologics
Market Cap: US$3.6b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$15.25
7D
4.7%
1Y
-4.4%
ACADIA Pharmaceuticals
Market Cap: US$3.6b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$21.73
7D
5.4%
1Y
50.1%
L&C BIOLTD
Market Cap: ₩1.3t
L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.
A290650
₩49,750.00
7D
1.8%
1Y
168.5%
HBM Holdings
Market Cap: HK$10.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$12.44
7D
-2.7%
1Y
864.3%
Sanjivani Paranteral
Market Cap: ₹2.5b
Operates as a pharmaceutical company in India.
531569
₹199.40
7D
-5.8%
1Y
-24.8%
Jagsonpal Pharmaceuticals
Market Cap: ₹14.5b
Engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally.
JAGSNPHARM
₹215.59
7D
-1.8%
1Y
19.5%
BioSyent
Market Cap: CA$125.6m
Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
RX
CA$11.21
7D
0.09%
1Y
0.4%
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.0b
Produces and sells medicines in China.
600285
CN¥23.08
7D
0.7%
1Y
-4.6%
RPG Life Sciences
Market Cap: ₹38.8b
An integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.
RPGLIFE
₹2,354.80
7D
3.4%
1Y
-0.2%